Clinical Trial Update: NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing [Phase 2]

View source ↗

Summary

NeoTRACK is a Phase 2 trial evaluating immuno-oncology efficacy in non-small cell lung cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING